首页> Cancer research> EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases.

EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases.

导出 OA

翻译打印收藏纠错

第一作者： Aria,Vaishnavi

第一单位： Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.

作者： Aria,Vaishnavi ^[1] ; Laura,Schubert ^[1] ; Uwe,Rix ^[2] ; Lindsay A,Marek ^[3] ; Anh T,Le ^[1] ; Stephen B,Keysar ^[1] ; Magdalena J,Glogowska ^[1] ; Matthew A,Smith ^[4] ; Severine,Kako ^[1] ; Natalia J,Sumi ^[2] ; Kurtis D,Davies ^[5] ; Kathryn E,Ware ^[3] ; Marileila,Varella-Garcia ^[1] ; Eric B,Haura ^[4] ; Antonio,Jimeno ^[1] ; Lynn E,Heasley ^[3] ; Dara L,Aisner ^[5] ; Robert C,Doebele ^[6]

作者单位： Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado. ^[1] Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. ^[2] Department of Craniofacial Biology, University of Colorado School of Dental Medicine, Aurora, Colorado. ^[3] Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. ^[4] Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado. ^[5] Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado. robert.doebele@ucdenver.edu. ^[6]